Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Well Lead Medical CoSHSE:603309 +2.22%75 5-Year Yield-on-Cost % is 17.71 as of Sep. 21, 2026, which is 237% above its 10-year median of 5.25. GuruFocus rates SHSE:603309 with a GF Score™ of 75/100 and a GF Value™ of ¥14.79 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 313 Medical Devices & Instruments companies, Well Lead Medical Co ranks better than 95.85% on this metric.
Well Lead Medical Co's yield on cost for the quarter that ended in Jun. 2026 was 17.71.
The historical rank and industry rank for Well Lead Medical Co's 5-Year Yield-on-Cost % or its related term are showing as below:
SHSE:603309'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.96 Med: 5.25 Max: 24.8
Current: 17.71
During the past 13 years, Well Lead Medical Co's highest Yield on Cost was 24.80. The lowest was 1.96. And the median was 5.25.
SHSE:603309's 5-Year Yield-on-Cost % is ranked better than 95.85% of 313
companies
in the Medical Devices & Instruments industry
Industry Median: 2.52
vs SHSE:603309: 17.71
Well Lead Medical Co (SHSE:603309) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Well Lead Medical Co 5-Year Yield-on-Cost % Related Terms
SHSE:603309 vs ISRG, BDX, RMD: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, Well Lead Medical Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Well Lead Medical Co 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Well Lead Medical Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Well Lead Medical Co's 5-Year Yield-on-Cost % falls into.
Well Lead Medical Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Well Lead Medical Co (SHSE:603309) has a 5-Year Yield-on-Cost % of 17.71 as of Sep. 21, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Well Lead Medical Co and its competitors. This is 237% above median its historical median of 5.25. Over the past decade, Well Lead Medical Co's 5-Year Yield-on-Cost % has ranged from 1.96 to 24.80. According to the industry distribution chart, Well Lead Medical Co ranks #13 out of 313 companies in the Medical Devices & Instruments industry, placing it in the top 4.2%.
Is Well Lead Medical Co's 5-Year Yield-on-Cost % too high?
Well Lead Medical Co's current 5-Year Yield-on-Cost % of 17.71 is 237% above median its 10-year median of 5.25. Over the past 10 years, this metric has ranged from a low of 1.96 to a high of 24.80. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.52. Well Lead Medical Co's value of 17.71 is 602.8% above this industry median. Based on the distribution chart, Well Lead Medical Co ranks #13 out of 313 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Well Lead Medical Co has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Well Lead Medical Co's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Well Lead Medical Co ranks #13 out of 313 companies for 5-Year Yield-on-Cost %. This places Well Lead Medical Co in the top 4% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.52. Well Lead Medical Co's value of 17.71 is 602.8% above this benchmark. Historically, Well Lead Medical Co's own 5-Year Yield-on-Cost % has ranged from 1.96 to 24.80 over the past decade. While the company's 10-year median is 5.25 vs. the industry median of 2.52, Well Lead Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.52, based on 313 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Well Lead Medical Co's current 5-Year Yield-on-Cost % of 17.71 is 602.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Well Lead Medical Co and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Well Lead Medical Co's current 5-Year Yield-on-Cost % is 17.71, which is 237% above median its own 10-year median of 5.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Well Lead Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Well Lead Medical Co (SHSE:603309) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥14.79, compared to a current price of ¥11.06 — trading 25.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 17.71, which is 237% above median its 10-year median of 5.25 and 602.8% above the Medical Devices & Instruments industry median of 2.52. Well Lead Medical Co's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Well Lead Medical Co (SHSE:603309), the current 5-Year Yield-on-Cost % is 17.71 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Well Lead Medical Co (SHSE:603309) Overvalued in 2026?
Based on GuruFocus' analysis, Well Lead Medical Co stock appears to be undervalued.
The current stock price of ¥11.06 is trading 25.2% below its estimated GF Value™ of ¥14.79.
GuruFocus considers Well Lead Medical Co to be Modestly Undervalued.
Key valuation signals for SHSE:603309:
5-Year Yield-on-Cost %: 17.71 (237% above median its 10-year median of 5.25)
GF Value™: ¥14.79 vs. price of ¥11.06 (25.2% below fair value)
Industry Position: 602.8% above the Medical Devices & Instruments median (#13 of 313)
No single metric tells the full story. See the SHSE:603309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressNo. 45-47, South of Guomao Avenue, No. 4, Area C, Jinhu Industrial City, Hualong Town, Panyu District, Guangdong Province, Guangzhou City, CHN, 511434
Well Lead Medical Co Ltd is engaged in research, production, and sales of medical catheters in anaesthesia, urology, respiratory and hemodialysis region. Its products include Endotracheal Tube, Standar Endotracheal Tube, and Suction Endotracheal Tube. The company products are used in surgery, treatment, first aid, and nursing. The company exports its products to North America, Europe, and Japan.
75GF Score
Get the complete analysis for SHSE:603309
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603309 has been successfully added to your 
